Bayer HealthCare Pharmaceuticals News RSS-Feed

Focus on Girls – Worldwide: Parliamentary Evening supported by Bayer HealthCare Pharmaceuticals and organized by the German Foundation for World Population

Tue, 24 Apr 2012 11:00:00 +0100

Equal opportunities are a human right, yet girls are still being disadvantaged: they suffer discrimination, are exposed to special health risks, are more frequently victims of violence, and have less access to education.

24 March - World Tuberculosis Day

Sat, 24 Mar 2012 12:00:00 +0100

Bayer HealthCare Pharmaceuticals supports the WHO and the TB Alliance in the fight against one of the most deadly infectious diseases in the world.

Together against tropical diseases

Mon, 20 Feb 2012 17:00:00 +0100

1.4 billion people worldwide suffer from at least one of the hitherto neglected tropical diseases

9th International Dialogue on Population and Sustainable Development

Tue, 15 Nov 2011 17:00:00 +0100

“Education Matters: Empowering Young People to Make Healthier Choices”

Better access to safe and affordable contraception in Uganda

Tue, 04 Oct 2011 10:30:00 +0100

Partnership between Bayer and USAID provides broad sections of the population in Uganda a better access to oral contraceptives

Methodological manual for sex education presented in Uganda

Mon, 12 Sep 2011 10:45:00 +0100

Bayer and DSW have jointly developed an innovative project on sex education

Women’s Healthcare as a Human Right:

Wed, 20 Apr 2011 17:00:00 +0100

the Bayer HealthCare Pharmaceuticals parliamentary forum

Rare Disease Day 2011

Tue, 01 Mar 2011 14:00:00 +0100

Bayer HealthCare Pharmaceuticals supports campaign for Pulmonary Hypertension

We cooperate with USAID to create sustainable contraceptive market in Africa

Thu, 13 Jan 2011 18:00:00 +0100

More than 215 Million women worldwide would like to use a contraceptive method, being able to choose the size of their family. However, in developing countries not all women do have access to modern contraceptive methods.

8th International Dialogue on Population and Sustainable Development 2010

Thu, 28 Oct 2010 17:00:00 +0100

Sexual self-determination as a human right – the Eighth Dialog Conference in Berlin develops a list of recommendations for politicians worldwide.

World Health Summit: Improving global access to medical research

Thu, 21 Oct 2010 16:30:00 +0100

The second World Health Summit was held in Charité Berlin on October 10 to 13, 2010, supported by Bayer Schering Pharma as one of its general partners. This year’s summit was held under the patronage of Angela Merkel, Chancellor of the Federal Republic of Germany, and Nicolas Sarkozy, President of the French Republic.

Focus on: World Heart Day 2010

Fri, 24 Sep 2010 12:30:00 +0100

World Heart Federation and Bayer Schering Pharma start common campaign “I Work with Heart” for the World Heart Day on 26^th September 2010.

Podcast: Results from a new study of treatment of thrombosis

Thu, 02 Sep 2010 13:38:00 +0100

The antioagulant drug Rivaroxaban can prevent thromboembolism in patients with deep vein thrombosis as effectively as the standard therapy.

Focus on: IMI – Innovative Medicines Initiative: Project Eu2P

Thu, 24 Jun 2010 17:18:00 +0100

Pharmaceutical companies and academic institutions have come together in the IMI and are jointly developing both a European master's degree course and a three-year doctorate program in this important field. This is the Eu2P project (European Program in Pharmacovigilance and Pharmacoepidemiology).

Research & Development: Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

Thu, 17 Jun 2010 16:40:00 +0100

Collaboration Focuses on the Discovery and Development of Multiple Antibody, Protein and Small Molecule Agents Targeting the Wnt Pathway.

Focus on: Bayer Schering Pharma launches drawing competition for young people impacted by MS

Wed, 26 May 2010 16:20:00 +0100

On World MS day, May 26th, Bayer Schering Pharma has launched of the Dreams for My Family contest for young artists impacted by MS. The global art competition allows children whose lives are affected by multiple sclerosis (MS) to express their future dreams for their families.

Research & Development: Bayer Presents New Riociguat Phase II Data

Tue, 18 May 2010 15:10:00 +0100

First Phase II study in patients with pulmonary hypertension owing to interstitial lung disease meets primary objectives / First long-term extension data of Phase II study in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension show sustained improvement in exercise capacity.

Research & Development: Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center

Mon, 17 May 2010 16:58:00 +0100

New U.S. Innovation Center in San Francisco’s Mission Bay will focus on developing partnerships with academic research institutions and small life science firms.

Focus on: IMI (Innovative Medicines Initiative) - The SAFESCIMET project

Fri, 30 Apr 2010 17:30:00 +0100

A new master's degree course to train experts in drug safety.

Just published: Corporate Responsibility - Patient organizations

Thu, 01 Apr 2010 08:18:00 +0100

Bayer Schering Pharma cooperates with patient organizations in all kinds of therapeutic areas. A list of patient organizations with which Bayer Schering Pharma and its affiliated companies in Germany and Europe cooperated in 2009 is now available online.

Just published: Corporate Responsibility - Donations

Wed, 31 Mar 2010 17:32:00 +0100

For us, donations are an effective way of expressing this responsibility and engaging in social action. A list of projects that Bayer Schering Pharma and cooperating companies supported with donations in 2009 is now available online.

On March 24 is World Tuberculosis Day

Tue, 23 Mar 2010 18:36:00 +0100

The fight against tuberculosis (TB), which tops the global statistics of fatal infectious diseases, is one of the greatest medical challenges of all. Bayer Schering Pharma is focusing on an innovative antibiotic in its search for new therapies.